[1]
D. V. Loi, “Clinical Outcomes of Aerosolized Versus Intravenous Colistin in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria”, J Clin Med Res, vol. 18, no. 1, pp. 42–49, Jan. 2026, doi: 10.14740/jocmr6415.